A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria.
Nikolaos SpernovasilisEvangelos I KritsotakisAnna MathioudakiAlexandra VouidaskiChristos SpaniasMaria PetrodaskalakiPetros IoannouGeorgios ChamilosDiamantis P KofteridisPublished in: The Journal of antimicrobial chemotherapy (2023)
Implementing and maintaining a carbapenem-focused ASP is feasible, effective and safe in settings with high rates of antimicrobial resistance, even during the COVID-19 pandemic.